These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 10331074)

  • 1. Cytochrome P-450 3A4: regulation and role in drug metabolism.
    Guengerich FP
    Annu Rev Pharmacol Toxicol; 1999; 39():1-17. PubMed ID: 10331074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.
    Tang W; Stearns RA
    Curr Drug Metab; 2001 Jun; 2(2):185-98. PubMed ID: 11469725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
    Schuetz JD; Schuetz EG; Thottassery JV; Guzelian PS; Strom S; Sun D
    Mol Pharmacol; 1996 Jan; 49(1):63-72. PubMed ID: 8569713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homotropic cooperativity of monomeric cytochrome P450 3A4 in a nanoscale native bilayer environment.
    Baas BJ; Denisov IG; Sligar SG
    Arch Biochem Biophys; 2004 Oct; 430(2):218-28. PubMed ID: 15369821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.
    Gillam EM; Baba T; Kim BR; Ohmori S; Guengerich FP
    Arch Biochem Biophys; 1993 Aug; 305(1):123-31. PubMed ID: 8342945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
    Labroo RB; Paine MF; Thummel KE; Kharasch ED
    Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
    Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
    Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
    Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes.
    Schuetz EG; Schuetz JD; Strom SC; Thompson MT; Fisher RA; Molowa DT; Li D; Guzelian PS
    Hepatology; 1993 Nov; 18(5):1254-62. PubMed ID: 8225233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytochrome P450 3A4 inducer metyrapone is an activator of the human pregnane X receptor.
    Wright MC
    Biochem Soc Trans; 1999 Aug; 27(4):387-91. PubMed ID: 10917608
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid.
    Wright MC; Wang XJ; Pimenta M; Ribeiro V; Paine AJ; Lechner MC
    Mol Pharmacol; 1996 Oct; 50(4):856-63. PubMed ID: 8863830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
    Schroer K; Kittelmann M; Lütz S
    Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyp3A regulation: from pharmacology to nuclear receptors.
    Quattrochi LC; Guzelian PS
    Drug Metab Dispos; 2001 May; 29(5):615-22. PubMed ID: 11302925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron shuttle between membrane-bound cytochrome P450 3A4 and b5 rules uncoupling mechanisms.
    Perret A; Pompon D
    Biochemistry; 1998 Aug; 37(33):11412-24. PubMed ID: 9708976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of glutathione on the catalytic activity of reconstituted cytochrome P450 3A4.
    Kim BR; Kim DH
    Biochem Biophys Res Commun; 1998 Jan; 242(1):209-12. PubMed ID: 9439637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable expression of human cytochrome P450 3A4 in conjunction with human NADPH-cytochrome P450 oxidoreductase in V79 Chinese hamster cells.
    Schneider A; Schmalix WA; Siruguri V; de Groene EM; Horbach GJ; Kleingeist B; Lang D; Böcker R; Belloc C; Beaune P; Greim H; Doehmer J
    Arch Biochem Biophys; 1996 Aug; 332(2):295-304. PubMed ID: 8806738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cytochromes P-450 2E1 and 3A4 in the 5-hydroxylation of salicylate in humans.
    Dupont I; Berthou F; Bodenez P; Bardou L; Guirriec C; Stephan N; Dreano Y; Lucas D
    Drug Metab Dispos; 1999 Mar; 27(3):322-6. PubMed ID: 10064561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glucocorticoid receptor is essential for induction of cytochrome P-4502B by steroids but not for drug or steroid induction of CYP3A or P-450 reductase in mouse liver.
    Schuetz EG; Schmid W; Schutz G; Brimer C; Yasuda K; Kamataki T; Bornheim L; Myles K; Cole TJ
    Drug Metab Dispos; 2000 Mar; 28(3):268-78. PubMed ID: 10681370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperativity in oxidations catalyzed by cytochrome P450 3A4.
    Ueng YF; Kuwabara T; Chun YJ; Guengerich FP
    Biochemistry; 1997 Jan; 36(2):370-81. PubMed ID: 9003190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and physical mechanisms of first-pass extraction.
    Hall SD; Thummel KE; Watkins PB; Lown KS; Benet LZ; Paine MF; Mayo RR; Turgeon DK; Bailey DG; Fontana RJ; Wrighton SA
    Drug Metab Dispos; 1999 Feb; 27(2):161-6. PubMed ID: 9929497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.